HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats.

Abstract
(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxi de (S 18986-1) is a new compound that facilitates post-synaptic responses by modulating alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor-mediated synaptic responses and thus promotes long-term potentiation and potentiates (S)-AMPA-induced release of noradrenaline in rat brain slices. In the present study, the effects of S 18986-1 were evaluated on cognitive functions by using a one-trial object-recognition test in the Wistar rat, a test which measures a form of episodic memory in rodents. Recognition was measured by the ability of treated rats to discriminate between a familiar and a new object after a 24-h retention delay. Oral administrations with S 18986-1 (0.3 to 100 mg/kg) 1 h before each session of the test improved object recognition at concentrations as low as 0.3 mg/kg. Under the same conditions, the nootropic drug aniracetam was active at a dose of 10 mg/kg by i.p. route. S 18986-1 was still effective on the object-recognition test when it was administered 4 h before each of the three sessions. Furthermore, subchronic oral pretreatment (7 days) with S 18986-1 (0.3 to 30 mg/kg) also increased the recognition of the familiar object indicating that the animals failed to develop tolerance to repeated administrations with S 18986-1. Finally, the recognition of the familiar object was improved when S 18986-1 was administered before the recognition trial whereas the rats failed to recognise the familiar object when S 18986-1 was administered before the sample presentation trial only. Taken together, the results indicated that S 18986-1 facilitated a form of episodic memory in the rat, by improving the recognition of a familiar information (retention). Furthermore, S 18986-1 was long-acting and demonstrated a good oral bioavailability. These data confer on S 18986-1, a potential role in improving episodic memory impaired in neurodegenerative diseases and during aging.
AuthorsC Lebrun, E Pillière, P Lestage
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 401 Issue 2 Pg. 205-12 (Aug 04 2000) ISSN: 0014-2999 [Print] Netherlands
PMID10924928 (Publication Type: Journal Article)
Chemical References
  • Benzothiadiazines
  • Nootropic Agents
  • Pyrrolidinones
  • S18986-1
  • aniracetam
Topics
  • Administration, Oral
  • Analysis of Variance
  • Animals
  • Benzothiadiazines (pharmacology)
  • Dose-Response Relationship, Drug
  • Injections, Intraperitoneal
  • Male
  • Memory (drug effects)
  • Nootropic Agents (pharmacology)
  • Psychomotor Performance (drug effects)
  • Pyrrolidinones (pharmacology)
  • Rats
  • Rats, Wistar
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: